SEC 13F Intelligence

Verdad Advisers, LP / AXSM

Verdad Advisers, LP’s Axsome Therapeutics Inc. Position

Does Verdad Advisers, LP own Axsome Therapeutics Inc. (AXSM)? Yes6.0K shares worth $1M (+1.14% of its 13F portfolio) as of Q1 2026.

Position Value
$1M
Q1 2026
Shares
6.0K
% of Portfolio
+1.14%
Quarters Held
1
currently held

Position History AXSM

Reported value by quarter
Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.0K$1M+1.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Verdad Advisers, LP’s full portfolio or all institutional holders of AXSM.